ctrl K

AI Score

Unlock

Kyverna Therapeutics Inc. (KYTX)

AI Score

Unlock

2.61

-0.23 (-8.10%)

At close: Mar 03, 2025, 3:59 PM

2.59

-0.77%

After-hours: Mar 03, 2025, 04:00 PM EST

Kyverna Therapeutics Income Statement

Table Mode

Year	FY23	FY22	FY21
Revenue	n/a	7.03M	5.66M
Cost of Revenue	1.71M	1.05M	586K
Gross Profit	-1.71M	5.97M	5.07M
Operating Income	-62.41M	-29.38M	-26.35M
Interest Income	2.28M	565K	1K
Pretax Income	-60.37M	-28.89M	-26.35M
Net Income	-60.37M	-28.89M	-26.35M
Selling & General & Admin	12.48M	8.01M	6.15M
Research & Development	49.92M	28.4M	25.85M
Other Expenses	-55K	-9K	-2K
Operating Expenses	62.41M	36.41M	32M
Interest Expense	187K	65K	3K
Selling & Marketing Expenses	n/a	n/a	n/a
Cost & Expenses	62.41M	36.41M	32M
Income Tax	n/a	56K	1K
Shares Outstanding (Basic)	673.62M	25.8M	25.8M
Shares Outstanding (Diluted)	673.62M	25.8M	25.8M
EPS (Basic)	-0.00	-1.12	-1.02
EPS (Diluted)	-0.00	-1.12	-1.02
EBITDA	-58.47M	-27.78M	-25.76M
Depreciation & Amortization	1.71M	1.05M	586K